Advance Relief for Rosacea
January 22, 2017
Category: Home
Tags: Untagged

First and only from Allergen : Rhofade for Redness in Adults Medscape (1/19, Brooks) reports the Food and Drug Administration “has approved oxymetazoline hydrochloride 1% cream (Rhofade, Allergan) for the topical treatment of persistent facial erythema associated with rosacea in adults.” David Nicholson, Allergan’s head of research and development, said in a news release, “Rhofade is the first and only alpha1A adrenoceptor agonist approved for persistent facial erythema associated with rosacea in adults. The approval of Rhofade represents a new prescription treatment that can effectively help physicians and their patients manage this condition.” Click image to schedule a visit with Dr. Jonathan Schreiber

Comments: